Please assess the completion status of the following clinical trial:

Trial Title: Effectiveness of Caudal Epidural Injections in Treatment of Chronic Low Back and Lower Extremity Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: EARLY_PHASE1
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* At least 18 years of age~* History of chronic, function-limiting low back pain of at least 6 months duration~* Able to give voluntary, written informed consent to participate,~* Able to understand the investigation, cooperate with the procedures, and willing to return for follow-up~* No recent surgical procedures within last three months~Exclusion Criteria:~* Cauda Equina symptoms and/or compressive radiculopathy~* Narcotic use of no greater than 100mg/day hydrocodone, 60mg Methadone. or 100mg morphine~* Uncontrolled major Depression or uncontrolled psychiatric disorder~* Uncontrolled or acute medical illnesses~* Chronic severe conditions that could interfere with outcome assessments~* Women who are pregnant or lactating~* Subjects who have participated in a clinical study with an investigational product within 30 days of enrollment~* Patients with multiple complaints involving concomitant hip osteoarthritis~* Inability to achieve proper positioning and inability to understand informed consent and protocol~* History of adverse reaction to local anesthetic or anti-inflammatory drugs and history of gastrointestinal bleeding or ulcers

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- local anesthetic (Type: ACTIVE_COMPARATOR): Group 1. local anesthetics only
- Local anesthetic with generic Celestone (Type: ACTIVE_COMPARATOR): Group 2. local anesthetic with 6mg of non-particulate Celestone
- Local anesthetic with Celestone (Type: ACTIVE_COMPARATOR): Group 3. local anesthetic with 6 mg of brand nameCelestone
- Local anesthetic with DepoMedrol (Type: ACTIVE_COMPARATOR): Group 4. local anesthetic with 40 mg of alcohol-free DepoMedrol

Based on this trial design, predict the completion outcome and termination type (if applicable).